Attach importance to the differential diagnosis of abnormal liver function in tuberculosis patients

doi:10.19983/j.issn.2096-8493.20220163

Abstract

Abstract:

Liver function injury is a common adverse drug reaction in the course of treatment of tuberculosis patients. Abnormal liver function can be caused by various types of hepatitis virus, drug or poison poisoning, autoimmune liver diseases, alcoholic liver disease, non-alcoholic fatty liver disease, cholestasis, et al.Sometimes it is difficult to diagnose the cause of liver injury. In clinical practice, it need to combine the history, biochemistry, etiology imaging and even liver biopsy to make a definite diagnosis. Clinically, in case of tuberculosis patients with abnormal liver function,it is necessary to identify the causes quickly and scientifically and intervene early meanwhile.It can contribute to the smooth progress of anti-tuberculosis treatment and improve the prognosis.

Key words: Tuberculosis, Hepatic insufficiency, Drug induced liver injury, Diagnosis, differential

CLC Number:

R447
R52

Ge Qiping, Gao Mengqiu. Attach importance to the differential diagnosis of abnormal liver function in tuberculosis patients[J]. Journal of Tuberculosis and Lung Disease , 2023, 4(2): 110-114. doi: 10.19983/j.issn.2096-8493.20220163

References 31

[1]	Shen T, Liu Y, Shang J, et al. Incidence and Etiology of Druginduced Liver Injury in Mainland China. Gastroenterology, 2019, 156(8): 2230-2241. doi:10.1053/j.gastro.2019.02.002. doi: S0016-5085(19)30364-6 pmid: 30742832
[2]	金小琳, 杨智彬, 詹淑华, 等. 1501例初治住院结核病患者肝功能异常的影响因素. 中华实验和临床感染病杂志(电子版), 2020, 14(5):394-400. doi:10.3877/cma.j.issn.1674-1358.2020.05.007. doi: 10.3877/cma.j.issn.1674-1358.2020.05.007
[3]	戈启萍, 王庆枫, 段鸿飞, 等. 含丙硫异烟胺和对氨基水杨酸治疗方案发生药物性肝损伤129例临床分析. 中华结核和呼吸杂志, 2013, 36(10):737-740. doi:10.3760/cma.j.issn.1001-0939.2013.10.008. doi: 10.3760/cma.j.issn.1001-0939.2013.10.008
[4]	吴玉华, 武谦虎. 抗结核药致肝损害1949例文献分析. 西北药学杂志, 2015(6):750-753. doi:10.3969/j.issn.1004-2407.2015.06.028. doi: 10.3969/j.issn.1004-2407.2015.06.028
[5]	Zhang T, Du J, Yin X, et al. Adverse Events in Treating Smear-Positive Tuberculosis Patients in China. Int J Environ Res Public Health, 2015, 13(1):86. doi:10.3390/ijerph13010086. doi: 10.3390/ijerph13010086 URL
[6]	张敏, 李星星, 何霞, 等. 抗结核治疗中药物肝损伤相关因素的logistic回归分析. 中国临床药理学杂志, 2021, 37(18):2387-2389,2393. doi:10.13699/j.cnki.1001-6821.2021.18.001. doi: 10.13699/j.cnki.1001-6821.2021.18.001
[7]	王丽君, 战寒秋. 药物性肝衰竭108例临床分析. 药物不良反应杂志, 2018, 20(3):169-175. doi:10.3760/cma.j.issn.1008-5734.2018.03.003. doi: 10.3760/cma.j.issn.1008-5734.2018.03.003
[8]	张静, 李文胜, 高微微. 抗结核药物治疗致患者肝损伤死亡二例并文献复习. 结核病与肺部健康杂志, 2017, 6(1):73-76. doi:10.3969/j.issn.2095-3755.2017.01.018. doi: 10.3969/j.issn.2095-3755.2017.01.018
[9]	路燕, 陈明月, 郑秀良, 等. 185例药物性肝损伤患者的临床特征分析. 安徽医学, 2022, 43(3):308-313. doi:10.3969/j.issn.1000-0399.2022.03.013. doi: 10.3969/j.issn.1000-0399.2022.03.013
[10]	中华医学会结核病学分会.抗结核药物性肝损伤诊治指南(2019年版). 中华结核和呼吸杂志, 2019, 42(5):343-356. doi:10.3760/cma.j.issn.1001-0939.2019.05.007. doi: 10.3760/cma.j.issn.1001-0939.2019.05.007
[11]	中华医学会感染病学分会, 肝脏炎症及其防治专家共识专家委员会. 肝脏炎症及其防治专家共识. 中华肝脏病杂志, 2014, 22(2):94-103. doi:10.3760/cma.j.issn.1007-3418.2014.02.006. doi: 10.3760/cma.j.issn.1007-3418.2014.02.006
[12]	杨松, 严晓峰, 唐神结. 浅谈结核病合并慢性肝病的抗结核药物治疗. 中华结核和呼吸杂志, 2020, 43(1):3-8. doi:10.3760/cma.j.issn.1001-0939.2020.01.002. doi: 10.3760/cma.j.issn.1001-0939.2020.01.002
[13]	中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型病毒性肝炎防治指南(2019年版). 中华肝脏病杂志, 2019, 27(12):938-961. doi:10.3760/cma.j.issn.1007-3418.2019.12.007. doi: 10.3760/cma.j.issn.1007-3418.2019.12.007
[14]	中华医学会肝病学分会, 中华医学会感染病学分会. 丙型肝炎防治指南(2019年版). 实用肝脏病杂志, 2020, 23(1):33-52. doi:10.3969/j.issn.1672-5069.2020.01.045. doi: 10.3969/j.issn.1672-5069.2020.01.045
[15]	鞠引, 金文娟. 2016—2019年住院肝功能异常患者病因分析. 智慧健康, 2021, 7(29):103-106. doi:10.19335/j.cnki.2096-1219.2021.29.034. doi: 10.19335/j.cnki.2096-1219.2021.29.034
[16]	Saha A, Shanthi FXM, Winston AB, et al. Prevalence of Hepatotoxicity From Antituberculosis Therapy: A Five-Year Experience From South India. J Prim Care Community Health, 2016, 7(3):171-174. doi:10.1177/2150131916642431. doi: 10.1177/2150131916642431 pmid: 27056794
[17]	陶磊, 陈庆, 祝建峰. 一线抗结核药物致肺结核患者药物性肝损伤发生情况分析. 中国药业, 2020, 29(16):70-72. doi:10.3969/j.issn.1006-4931.2020.16.022. doi: 10.3969/j.issn.1006-4931.2020.16.022
[18]	周裕松, 张岩. 恩替卡韦在慢性HBV携带者抗结核治疗中对ALT、TBIL的影响. 大医生, 2019, 4(23):162-164.
[19]	Kim WS, Lee SS, Lee CM, et al. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury. BMC Infect Dis, 2016, 16:50. doi:10.1186/s12879-016-1344-2. doi: 10.1186/s12879-016-1344-2 pmid: 26833347
[20]	Lomtadze N, Kupreishvili L, Salakaia A, et al. Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis. PLoS One, 2013, 8(12):e83892. doi:10.1371/journal.pone.0083892. doi: 10.1371/journal.pone.0083892 URL
[21]	马雄. 自身免疫性肝病的诊治:从共识到指南. 中华肝脏病杂志, 2016, 24(1):3-4. doi:10.3760/cma.j.issn.1007-3418.2016.01.003. doi: 10.3760/cma.j.issn.1007-3418.2016.01.003
[22]	中华医学会肝病学分会. 自身免疫性肝炎诊断和治疗指南(2021). 临床肝胆病杂志, 2022, 38(1):42-49. doi:10.3969/j.issn.1001-5256.2022.01.008. doi: 10.3969/j.issn.1001-5256.2022.01.008
[23]	付丽红, 刘坤, 余卓, 等. 肝脏病理检测对不明原因肝功能异常的临床诊断价值. 中西医结合肝病杂志, 2021, 31(3):202-204. doi:10.3969/j.issn.1005-0264.2021.03.004. doi: 10.3969/j.issn.1005-0264.2021.03.004
[24]	中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 酒精性肝病防治指南(2018更新版). 中华肝脏病杂志, 2018, 26(3):188-194. doi:10.3760/cma.j.issn.1007-3418.2018.03.007. doi: 10.3760/cma.j.issn.1007-3418.2018.03.007
[25]	王萍, 李秀婷. 酒精对成人肺结核抗结核药物肝损伤的影响. 中国现代药物应用, 2013, 7(15):53-54. doi:10.3969/j.issn.1673-9523.2013.15.040. doi: 10.3969/j.issn.1673-9523.2013.15.040
[26]	Abdelbasset WK, Tantawy SA, Kamel DM, et al. Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease:a comparative randomized controlled trial. Medicine(Baltimore), 2020, 99 (10):e19471. doi:10.1097/MD.0000000000019471. doi: 10.1097/MD.0000000000019471
[27]	王永斌, 陆奎英, 苏勇, 等. 非酒精性脂肪肝患者肝功能、氧化应激水平变化及临床意义. 检验医学, 2020, 35(9):903-907. doi:10.3969/j.issn.1673-8640.2020.09.011. doi: 10.3969/j.issn.1673-8640.2020.09.011
[28]	程浩, 潘静, 姚甜甜, 等. 全身炎症反应导致肝损伤的临床特点和机制研究现状. 国际病毒学杂志, 2019, 26(5):354-357. doi:10.3760/cma.j.issn.1673-4092.2019.05.018. doi: 10.3760/cma.j.issn.1673-4092.2019.05.018
[29]	葛文君. 心源性肝损害临床病例报道分析2例. 医师在线, 2021, 11(8):32-33. doi:10.3969/j.issn.2095-7165.2021.08.023. doi: 10.3969/j.issn.2095-7165.2021.08.023
[30]	张岱, 王炳元. 宿主因素决定药物常规剂量下的肝损伤. 肝博士, 2021 (6):42-44.
[31]	何涛, 汪峰, 唐武. 抗结核药致药物性肝损伤危险因素的logistic回归分析. 中国药房, 2016, 27(12):1626-1628. doi:10.6039/j.issn.1001-0408.2016.12.15. doi: 10.6039/j.issn.1001-0408.2016.12.15